Filing Details
- Accession Number:
- 0001209191-23-031889
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-05-24 16:39:01
- Reporting Period:
- 2023-05-22
- Accepted Time:
- 2023-05-24 16:39:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1750019 | Tcr2 Therapeutics Inc. | TCRR | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1134657 | Luke Evnin | C/O Mpm Capital 399 Boylston Street, Suite 1100 Boston MA 02116 | No | No | Yes | No | |
| 1263048 | Mpm Asset Management Llc | C/O Mpm Capital 399 Boylston Street, Suite 1100 Boston MA 02116 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-05-22 | 178,269 | $0.74 | 374,171 | No | 4 | X | Direct | |
| Common Stock | Disposition | 2023-05-22 | 70,170 | $1.88 | 304,001 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | X | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Common Stock Warrant (Right To Buy) | Disposition | 2023-05-22 | 42,761 | $0.00 | 42,761 | $0.74 |
| Common Stock | Common Stock Warrant (Right to Buy) | Disposition | 2023-05-22 | 135,508 | $0.00 | 135,508 | $0.74 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2016-12-13 | 2026-12-12 | No | 4 | X | Direct |
| 0 | 2017-12-06 | 2027-12-05 | No | 4 | X | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 3,370,977 | Indirect | See Footnote |
Footnotes
- On May 22, 2023, MPM Asset Management LLC ("AM LLC") exercised warrants to purchase 178,269 shares of the Issuer's common stock for $0.74 a share. AM LLC paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 70,170 of the warrant shares to satisfy the exercise price and issuing to AM LLC the remaining 108,099 shares.
- The shares are held as follows: 3,056,272 by MPM BioVentures 2014, L.P. ("BV 2014"), 203,846 by MPM BioVentures 2014(B), L.P. ("BV 2014(B)") and 110,859 by MPM Asset Management Investors BV2014 LLC ("AM BV2014"). MPM BioVentures 2014 GP LLC and MPM BioVentures 2014 LLC ("BV LLC") are the direct and indirect general partners of BV 2014 and BV 2014(B) and BV LLC is the manager of AM BV 2014. Luke Evnin is a managing director of BV LLC and disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Billionaire Hedge Funds
